Skip to main navigation Skip to search Skip to main content

Serum fucose as a monitor for recurrent malignancy

  • Marc K. Wallack
  • , Arthur S. Brown
  • , Ernest F. Rosato
  • , Stephen Rubin
  • , Joan L. Johnson
  • , Francis E. Rosato
  • University of Pennsylvania

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Serum fucose determinations were performed on 19 patients with “stable” or “inactive” malignancies, 33 patients with “active” malignancies, and 14 “normals.” A significant difference in the values between “normal” and “stable” patients and those with “active” cancer is shown. A role for this relatively simple serological test for diagnosing and following metastatic cancer is suggested.

Original languageEnglish
Pages (from-to)39-44
Number of pages6
JournalJournal of Surgical Oncology
Volume10
Issue number1
DOIs
StatePublished - 1978

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • cancer
  • diagnosis
  • fucose

Fingerprint

Dive into the research topics of 'Serum fucose as a monitor for recurrent malignancy'. Together they form a unique fingerprint.

Cite this